MedPath

Open vs Laparoscopic Liver Surgery for Colorectal Liver Metastases

Not Applicable
Completed
Conditions
Laparoscopic Liver Resection
Colorectal Liver Metastasis
Interventions
Procedure: Liver resection
Registration Number
NCT02727179
Lead Sponsor
Hospital Universitario Virgen de la Arrixaca
Brief Summary

This study evaluates the feasibility of laparoscopic surgery in patients diagnosed with colorectal liver metastases. Half of participants will be operated on by laparoscopic approach and the results obtained will be compared with the results from the other half of patients operated on by open approach.

Detailed Description

The safety and efficacy of liver surgery in the treatment of colorectal liver metastases are well established for the open approach. It allows good results in terms of complications, disease free survival and overall survival, and for these reasons it has become the gold standard technique in the treatment of colorectal liver metastases.

On the contrary, the role of laparoscopic liver resection in this context is not so clear nowadays. Generally, laparoscopic surgery offers some advantages such as less pain, shorter hospital stay and better aesthetic results. But the use of laparoscopic approach in liver surgery is still discussing: two international consensus conferences have been held and no strong conclusions have been made. Furthermore for colorectal liver metastases no randomized trials, comparing both techniques, have been published until now.

To assess the feasibility of laparoscopic liver resection for colorectal metastases, the investigators propose this trial in which the patients suitable for laparoscopic approach are randomized to open or laparoscopic group

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients with colorectal liver metastases;
  • Patients suitable for surgical treatment;
  • Patients eligible for laparoscopy approach.
Exclusion Criteria
  • Patients with high tumour load: multiples and bilobar colorectal metastases;
  • Patients with big liver metastases or close to major vessels;
  • Patients with oncological contraindications for surgery;
  • Cirrhotic liver
  • Needing for two stage liver resection;
  • Medical or psychiatric condition of the patient that compromises the informed consent authorization;
  • Refusal to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Open groupLiver resectionLiver resection performed by open approach
Laparoscopic groupLiver resectionLiver resection performed by laparoscopic approach
Primary Outcome Measures
NameTimeMethod
Overall survival1 year
Secondary Outcome Measures
NameTimeMethod
Hospital stayUp to 3 months

Days between surgical operation and hospital discharge

Blood lossesIntraoperative

Blood loss in milliliter

TransfusionIntraoperative

Number of blood transfusions required during surgical operation

Mortality90 days
Morbidity90 days
Surgical operative timeIntraoperative

Duration of the surgical intervention

Time between surgery and adjuvant chemotherapyUp to 3 months

Days between surgical operation and the beginning of adjuvant chemotherapy

Trial Locations

Locations (1)

Hospital Universitario "Virgen de la Arrixaca"

🇪🇸

Murcia, Spain

© Copyright 2025. All Rights Reserved by MedPath